Evolving Treatment Paradigms for Renal Cell Carcinoma

EP. 1: Newly Diagnosed Metastatic Renal Cell Carcinoma

July 11th 2018

EP. 2: mRCC Patient Selection for Ipilimumab/Nivolumab

July 11th 2018

EP. 3: mRCC: Cytoreductive Nephrectomy in the Modern Era

July 11th 2018

EP. 4: Risk Stratification for Metastatic Renal Cell Carcinoma

July 11th 2018

EP. 5: Selecting Immunotherapy versus VEGF TKI for mRCC

July 11th 2018

EP. 6: Deferred Therapy for Favorable-Risk mRCC Patients

July 11th 2018

EP. 7: VEGF TKI + Immunotherapy Combinations for mRCC

July 11th 2018

EP. 8: Sunitinib 4/2 vs 2/1 Schedule for Patients with mRCC

July 11th 2018

EP. 9: Disease Progression in Patients with Metastatic RCC

July 11th 2018

EP. 10: Sequencing Approaches in Metastatic Renal Cell Carcinoma

July 11th 2018

EP. 11: Considerations for Using Adjuvant Therapy in mRCC

July 11th 2018

EP. 12: Evolving Treatment Landscape of Renal Cell Carcinoma

July 11th 2018